The TCM Mid-Cap Equity Strategy invests in a concentrated portfolio of high-quality mid-cap businesses with durable competitive advantages. Through disciplined fundamental research and high-conviction investing, we seek to identify tomorrow’s market leaders while they are still in the earlier stages of their growth journey.
Our investment process focuses on exceptional businesses with strong management teams, attractive long-term growth prospects, and the ability to compound earnings and free cash flow over many years. The result is a differentiated portfolio designed to capture the growth potential of emerging market leaders while maintaining the quality and discipline that define the TCM investment approach.
20-25 all-cap companies, our highest conviction ideas
The portfolio is consistently ~85% different from the market
Well-managed companies that can compound growth of our clients’ investment capital over time
Looking beyond the market consensus view toward true contributors to long term shareholder value creation
Managing for attractive after-tax returns
Seeking to ensure agility thus improving opportunity for superior risk-adjusted return
Managed for risk-adjusted returns without regard to tracking error. Mindful of sector and country weightings but focused on best ideas
Continuous portfolio and company monitoring with proprietary “moat trajectory” analysis
The Mid-Equity Growth portfolio is constructed from the bottom up, based on discovery and analysis conducted with a long-term, fundamentals-based perspective.
Current and future portfolio holdings are subject to change and risk. References to these companies are not a solicitation or a recommendation to buy, hold or sell any securities. The holdings presented are classified using Global Industry Classification Standards (GICS).
